Oxbow Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,650
| Closed | -$431K | – | 242 |
|
|
2024
Q2 | $431K | Hold |
4,650
| – | – | 0.05% | 152 |
|
|
2024
Q1 | $441K | Buy |
+4,650
| New | +$441K | 0.06% | 135 |
|
|
2023
Q1 | – | Sell |
-5,850
| Closed | -$486K | – | 225 |
|
|
2022
Q4 | $486K | Hold |
5,850
| – | – | 0.09% | 131 |
|
|
2022
Q3 | $464K | Hold |
5,850
| – | – | 0.07% | 160 |
|
|
2022
Q2 | $434K | Hold |
5,850
| – | – | 0.06% | 173 |
|
|
2022
Q1 | $526K | Buy |
5,850
+2,350
| +67% | +$211K | 0.05% | 179 |
|
|
2021
Q4 | $392K | Buy |
+3,500
| New | +$392K | 0.04% | 212 |
|